Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Riche

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
The American Journal of the Medical Sciences|March 27, 2009
Impact of sitagliptin on markers of beta-cell function: a meta-analysisDaniel M Riche, Honey E East, Krista D Riche
Diabetes Care|March 30, 2007
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome: response to Bakris et alKristel J O'Malley, Marshall J Bouldin, Daniel M Riche
JAMA|March 6, 2014
Deaths and cardiovascular events in men receiving testosteroneDaniel M Riche, William L Baker, Christian A Koch
Drug Design, Development and Therapy|January 29, 2014
Transdermal testosterone replacement therapy in menM Iftekhar Ullah, Daniel M Riche, Christian A Koch
Journal of the Mississippi State Medical Association|October 26, 2012
Top 10 facts you should know about diabetesRosemary J Call, Marion R Wofford, Daniel M Riche
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|March 2, 2010
Medication-induced adverse effects: important concepts for the hand therapistDaniel M Riche, John D Cleary, S Travis King
Journal of the American Pharmacists Association : Japha|November 21, 2008
Practical management of dyslipidemia with elevated lipoprotein(a)Daniel M Riche, Honey E East, Heather M Priest
The Annals of Pharmacotherapy|December 7, 2013
Response to "lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapy"Joshua W Fleming, Katie S McClendon, Daniel M Riche
The Annals of Pharmacotherapy|June 27, 2013
New obesity agents: lorcaserin and phentermine/topiramateJoshua W Fleming, Katie S McClendon, Daniel M Riche
Expert Opinion on Drug Safety|December 10, 2009
Orlistat: current status in clinical therapeuticsKatie S McClendon, Daniel M Riche, Gabriel Ikponmosa Uwaifo
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
The American Journal of the Medical Sciences|March 27, 2009
Impact of sitagliptin on markers of beta-cell function: a meta-analysisDaniel M Riche, Honey E East, Krista D Riche
Diabetes Care|March 30, 2007
Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome: response to Bakris et alKristel J O'Malley, Marshall J Bouldin, Daniel M Riche
JAMA|March 6, 2014
Deaths and cardiovascular events in men receiving testosteroneDaniel M Riche, William L Baker, Christian A Koch
Drug Design, Development and Therapy|January 29, 2014
Transdermal testosterone replacement therapy in menM Iftekhar Ullah, Daniel M Riche, Christian A Koch
Journal of the Mississippi State Medical Association|October 26, 2012
Top 10 facts you should know about diabetesRosemary J Call, Marion R Wofford, Daniel M Riche
Journal of Hand Therapy : Official Journal of the American Society of Hand Therapists|March 2, 2010
Medication-induced adverse effects: important concepts for the hand therapistDaniel M Riche, John D Cleary, S Travis King
Journal of the American Pharmacists Association : Japha|November 21, 2008
Practical management of dyslipidemia with elevated lipoprotein(a)Daniel M Riche, Honey E East, Heather M Priest
The Annals of Pharmacotherapy|December 7, 2013
Response to "lorcaserin and phentermine/topiramate: two leaps forward in weight loss pharmacotherapy"Joshua W Fleming, Katie S McClendon, Daniel M Riche
The Annals of Pharmacotherapy|June 27, 2013
New obesity agents: lorcaserin and phentermine/topiramateJoshua W Fleming, Katie S McClendon, Daniel M Riche
Expert Opinion on Drug Safety|December 10, 2009
Orlistat: current status in clinical therapeuticsKatie S McClendon, Daniel M Riche, Gabriel Ikponmosa Uwaifo
Pageof 5